Ha habido 50 transacciones internas recientes registradas para PDS Biotechnology Corporation (PDSB), incluyendo 47 compras y 0 ventas. El total de compras internas fue valorado en $9.26M y el total de ventas internas en RSU Award.
Internos destacados con actividad reciente incluyen Brawley Otis W, Glover Stephen C., Boesgaard Lars. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — PDSB
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-01-12 |
Brawley Otis W |
Director |
Concesión de RSU |
54,876 |
$0.98 |
$53.78K |
54,876 |
| 2026-01-12 |
Glover Stephen C. |
Director |
Concesión de RSU |
54,876 |
$0.98 |
$53.78K |
54,876 |
| 2026-01-12 |
Boesgaard Lars |
Chief Financial Officer |
Concesión de RSU |
300,000 |
$0.98 |
$294K |
300,000 |
| 2026-01-12 |
Freitag Gregory Gene |
Director |
Concesión de RSU |
54,876 |
$0.98 |
$53.78K |
54,876 |
| 2026-01-12 |
Ali-jackson Kamil |
Director |
Concesión de RSU |
54,876 |
$0.98 |
$53.78K |
54,876 |
| 2026-01-12 |
Toutain Stephan |
Chief Operating Officer |
Concesión de RSU |
300,000 |
$0.98 |
$294K |
300,000 |
| 2026-01-12 |
Conn Gregory |
Chief Scientific Officer |
Concesión de RSU |
150,000 |
$0.98 |
$147K |
150,000 |
| 2026-01-12 |
Bedu-addo Frank |
President/ceo |
Concesión de RSU |
548,782 |
$0.98 |
$537.81K |
548,782 |
| 2026-01-12 |
Iliev Ilian |
Director |
Concesión de RSU |
54,876 |
$0.98 |
$53.78K |
54,876 |
| 2026-01-12 |
Brown Spencer D. |
Senior VP, General Counsel |
Concesión de RSU |
300,000 |
$0.98 |
$294K |
300,000 |
| 2026-01-12 |
Shepard Kirk V. |
Chief Medical Officer |
Concesión de RSU |
300,000 |
$0.98 |
$294K |
300,000 |
| 2025-06-12 |
Boesgaard Lars |
Chief Financial Officer |
Concesión de RSU |
150,000 |
$1.79 |
$268.5K |
150,000 |
| 2025-06-12 |
Toutain Stephan |
Chief Operations Officer |
Concesión de RSU |
150,000 |
$1.79 |
$268.5K |
150,000 |
| 2025-06-12 |
Conn Gregory |
Chief Scientific Officer |
Concesión de RSU |
40,000 |
$1.79 |
$71.6K |
40,000 |
| 2025-06-12 |
Bedu-addo Frank |
President/ceo |
Concesión de RSU |
150,000 |
$1.79 |
$268.5K |
150,000 |
| 2025-06-12 |
Brown Spencer D. |
Senior VP, General Counsel |
Concesión de RSU |
150,000 |
$1.79 |
$268.5K |
150,000 |
| 2025-06-12 |
Shepard Kirk V. |
Chief Medical Officer |
Concesión de RSU |
150,000 |
$1.79 |
$268.5K |
150,000 |
| 2025-06-11 |
Brawley Otis W |
Director |
Concesión de RSU |
22,700 |
$1.75 |
$39.73K |
22,700 |
| 2025-06-11 |
Glover Stephen C. |
Director |
Concesión de RSU |
22,700 |
$1.75 |
$39.73K |
22,700 |
| 2025-06-11 |
Freitag Gregory Gene |
Director |
Concesión de RSU |
22,700 |
$1.75 |
$39.73K |
22,700 |
| 2025-06-11 |
Ali-jackson Kamil |
Director |
Concesión de RSU |
22,700 |
$1.75 |
$39.73K |
22,700 |
| 2025-06-11 |
Iliev Ilian |
Director |
Concesión de RSU |
22,700 |
$1.75 |
$39.73K |
22,700 |
| 2025-02-28 |
Glover Stephen C. |
Director |
Compra Informativa |
15,061 |
$1.53 |
$23.04K |
15,061 |
| 2025-02-28 |
Freitag Gregory Gene |
Director |
Compra Informativa |
15,060 |
$1.53 |
$23.04K |
15,060 |
| 2024-06-24 |
Brawley Otis W |
Director |
Concesión de RSU |
9,000 |
$2.86 |
$25.74K |
9,000 |
| 2024-06-24 |
Glover Stephen C. |
Director |
Concesión de RSU |
9,000 |
$2.86 |
$25.74K |
9,000 |
| 2024-06-24 |
Sykes Richard |
Director |
Concesión de RSU |
9,000 |
$2.86 |
$25.74K |
9,000 |
| 2024-06-24 |
Freitag Gregory Gene |
Director |
Concesión de RSU |
9,000 |
$2.86 |
$25.74K |
9,000 |
| 2024-06-24 |
Ali-jackson Kamil |
Director |
Concesión de RSU |
9,000 |
$2.86 |
$25.74K |
9,000 |
| 2024-06-24 |
Iliev Ilian |
Director |
Concesión de RSU |
9,000 |
$2.86 |
$25.74K |
9,000 |
| 2024-05-01 |
Toutain Stephan |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-05-01 |
Toutain Stephan |
Chief Operations Officer |
Concesión de RSU |
200,000 |
$3.61 |
$722K |
200,000 |
| 2024-02-28 |
Conn Gregory |
Chief Scientific Officer |
Concesión de RSU |
46,648 |
$5.87 |
$273.82K |
46,648 |
| 2024-02-28 |
Bedu-addo Frank |
President/ceo |
Concesión de RSU |
300,000 |
$5.87 |
$1.76M |
300,000 |
| 2024-02-28 |
Brown Spencer D. |
Senior VP, General Counsel |
Concesión de RSU |
56,000 |
$5.87 |
$328.72K |
56,000 |
| 2024-01-22 |
Shepard Kirk V. |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-01-22 |
Shepard Kirk V. |
Chief Medical Officer |
Concesión de RSU |
200,000 |
$4.49 |
$898K |
200,000 |
| 2023-12-04 |
Boesgaard Lars |
Officer |
Desconocido |
- |
- |
- |
- |
| 2023-12-04 |
Boesgaard Lars |
Chief Financial Officer |
Concesión de RSU |
200,000 |
$5.28 |
$1.06M |
200,000 |
| 2023-07-14 |
Brawley Otis W |
Director |
Concesión de RSU |
9,000 |
$5.13 |
$46.17K |
9,000 |
| 2023-07-14 |
Glover Stephen C. |
Director |
Concesión de RSU |
9,000 |
$5.13 |
$46.17K |
9,000 |
| 2023-07-14 |
Sykes Richard |
Director |
Concesión de RSU |
9,000 |
$5.13 |
$46.17K |
9,000 |
| 2023-07-14 |
Freitag Gregory Gene |
Director |
Concesión de RSU |
9,000 |
$5.13 |
$46.17K |
9,000 |
| 2023-07-14 |
Ali-jackson Kamil |
Director |
Concesión de RSU |
9,000 |
$5.13 |
$46.17K |
9,000 |
| 2023-07-14 |
Iliev Ilian |
Director |
Concesión de RSU |
9,000 |
$5.13 |
$46.17K |
9,000 |
| 2023-01-05 |
Hill Matthew C |
Chief Financial Officer |
Concesión de RSU |
161,200 |
- |
- |
161,200 |
| 2023-01-05 |
Wood Lauren |
Chief Medical Officer |
Concesión de RSU |
110,800 |
- |
- |
110,800 |
| 2023-01-05 |
Conn Gregory |
Chief Scientific Officer |
Concesión de RSU |
137,200 |
- |
- |
137,200 |
| 2023-01-05 |
Bedu-addo Frank |
President/ceo |
Concesión de RSU |
385,300 |
- |
- |
385,300 |
| 2023-01-05 |
Brown Spencer D. |
Senior VP, General Counsel |
Concesión de RSU |
20,400 |
- |
- |
20,400 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
